Sun Pharma is axing its R&D crowd
Advertisement
After cutting out 150 senior executives,Sun Pharmaceutical Industries is yet again axing staff even after acquiring the $3.2-billion acquisition of Ranbaxy Laboratories.
This time, around 15 staff members from research and development department would be asked to leave asSun Pharma integrates a combined staff base that's 30,000 strong.
"A thorough assessment has been made of current overlaps across the organisation. While all attempts have been made to ensure that most employees are accommodated in various positions, there will be a few who we need to help in the process of actually transitioning out of the organisation,” said company’s spokesperson.
"We have to be realistic and prepare for adverse news ahead," managing director Dilip Shanghvi told analysts on the July 20 conference call.
(Image: Reuters)
Advertisement
Advertisement
This time, around 15 staff members from research and development department would be asked to leave as
"A thorough assessment has been made of current overlaps across the organisation. While all attempts have been made to ensure that most employees are accommodated in various positions, there will be a few who we need to help in the process of actually transitioning out of the organisation,” said company’s spokesperson.
"We have to be realistic and prepare for adverse news ahead," managing director Dilip Shanghvi told analysts on the July 20 conference call.
(Image: Reuters)
Advertisement
- Should you be worried about the potential side-effects of the Covishield vaccine?
- India T20 World Cup squad: KulCha back on menu, KL Rahul dropped
- Sales of homes priced over ₹4 crore rise 10% in Jan-Mar in top 7 cities: CBRE
- Gold prices fluctuate as geopolitical tensions ease; US Fed meeting, payroll data to affect prices this week
- Best beaches to visit in Goa in 2024
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market